Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

Phase 1Safety & dosage

1(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Other(2)

Detailed Status

unknown2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (100.0%)

Trials by Status

completed133%

unknown267%

Recent Activity

0 active trials

Showing 3 of 3

completed

Serum Vitamin D Levels in Critically Ill Patients Undergoing Regional Citrate Anticoagulation CRRT

NCT02414386

unknownphase_1

A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma

NCT01412307

unknown

Semaphorins 3A and 4D Levels in Heart Failure Patients

NCT02406716

Clinical Trials (3)

Showing 3 of 3 trials

NCT02414386

Serum Vitamin D Levels in Critically Ill Patients Undergoing Regional Citrate Anticoagulation CRRT

Completed

NCT01412307Phase 1

A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma

Unknown

NCT02406716

Semaphorins 3A and 4D Levels in Heart Failure Patients

Unknown

All 3 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 3